Charlotte Egeland

Charlotte Egeland

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Charlotte Egeland has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Computer Vision-Based Retrieval of Steps and Errors in Laparoscopic Cholecystectomy

    by Elaine Sui, Charlotte Egeland, Xiaohan Wang, Alfred Song, Rui Li, Joshua Villarreal, Anita Rau, Josiah Aklilu, Alan Brown, Shelly Goel, et al.

    Traditional surgical training relies heavily on hands-on experiences gained through relatively infrequent procedures during apprenticeships. Recently, postoperative review has become a valuable supplement to this model, offering learning opportunities outside the operating room. However, its adoption remains limited due to its inefficiencies. In this study, we developed a Computer Vision-based system designed to efficiently navigate and retrieve critical segments from laparoscopic cholecystectomy videos. Trained on a manually annotated dataset of 683 videos from six different sources, our model is taught to identify five distinct surgical steps and three common intraoperative errors: bleeding, bile spillage, and thermal injury. The resulting models demonstrated strong generalizability in identifying steps to unseen data from new hospitals. Large-scale analysis further revealed correlations between model-predicted error events and surgical step, disease severity, and surgical skill that align with established clinical knowledge. By facilitating the rapid retrieval of clinically relevant events, this tool enhances postoperative review practical, ultimately expediting surgical training.

  • Open Access

    Automated Video-Based Analysis of Surgical Meta-competencies Using Computer Vision

    by Josiah Aklilu, Joshua A. Villarreal, Chloe K. Nobuhara, Charlotte Egeland, Xiaohan Wang, Elaine Sui, Alan Brown, Matthew Leipzig, Reid Dale, Anita Rau, et al.

    Background: Traditional surgical training relies on an apprenticeship model, which is subjective and threatened by human bias. Performance metric scales attempt to offer more objective feedback by providing a structured grading rubric, but these scores are still ultimately subjective. Leveraging computer vision and artificial intelligence to assess surgical performance has the potential to shift subjective measurements into automated and objective feedback for trainees. Materials and Methods: This retrospective, multi-institutional study analyzed 319 laparoscopic cholecystectomy videos from IRB-approved deidentified datasets and segmented the videos into 2862 clips. Using an internally validated video-based assessment rubric, we annotated video clips across five metacompetency domains: tissue handling, psychomotor skills, efficiency, dissection quality, and exposure quality. Short video segments ( < 90s) were rated on a 5-point scale by expert raters. We trained a deep learning model (DINOv2) to classify composite high (4–5) vs low (1–3) metacompetency scores, representing yes/no binary feedback, a realistic comparison to the operating room. Model performance was evaluated via area under the receiver operating characteristic curve. Results: Among 2862 LC video clips, model performance was highest for dissection quality during the exposing gallbladder step (AUROC 91.5%, 95% confidence interval [CI], 84.5-96.5). Moderate performance was observed for efficiency (AUROC 72.6%, 95% CI 59.9-83.2) and exposure quality (AUROC 68.7%, 95% CI 55.2-81.8). Dissection and exposure quality scores during hepatocystic triangle dissection yielded AUROCs of 63.8% (95% CI 56.9-71.3) and 66.0% (95% CI 53.1-76.7), respectively. Conclusion: We demonstrate the feasibility of a purely vision-based deep learning model to grade surgical skill based on metacompetencies with excellent performance during simple steps. This technique represents an advance over prior whole-video approaches that rely heavily on tool- tracking and kinematic data, and may lead to greater model performance by using binary feedback on increasingly specific step segmentation.


  • Open Access

    Calcium electroporation of esophageal cancer induces gene expression changes: a sub-study of a phase I clinical trial

    by Charlotte Egeland, Lukas Balsevicius, Ismail Gögenur, Julie Gehl, Lene Baeksgaard, Rajendra Singh Garbyal, Michael Patrick Achiam

    Purpose: In this study, we aim to investigate gene expression changes in tumor samples obtained from patients with esophageal cancer treated with calcium electroporation. Previously, local treatment with calcium electroporation has been shown to induce gene expression alterations, potentially contributing to a more tumor-hostile microenvironment. Methods: In this sub-study of a phase I clinical trial, we included five patients with esophageal cancer treated with calcium electroporation. We compared cancer-associated gene expression patterns in tumor samples before and after treatment. Furthermore, we used linear support vector regression to predict the cellular composition of tumor samples. Results: Using differential expression analysis, we identified the downregulation of CXCL14 and upregulation of CCL21, ANGPTL4, and CRABP2 genes. We also found a decreased predicted proportion of dendritic cells while the proportion of neutrophils was increased. Conclusion: This study provides evidence that calcium electroporation for esophageal cancer induces local transcriptional changes and possibly alters the cellular composition of the tumor microenvironment. The results are explorative, larger studies are needed to confirm and further correlate our findings with clinical outcomes.


  • Open Access

    Staging Accuracy and Lymph Node Involvement in Superficial Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus—a Multicenter Case Series Analysis

    by Charlotte Egeland, Anne Sofie Grundahl, Cecilie Hübner, Daniel Kjaer, Sarunas Dikinis, Hanne Grossjohann, Michael Patrick Achiam

    At an early stage, esophageal cancer can be removed surgically or endoscopically. T1a tumors are removed by endoscopic resection, whereas T1b tumors are preferably surgically removed (esophagectomy) due to possible lymph node involvement. However, the diagnostic tools (endoscopic ultrasonography (EUS) and CT/PET-CT) used to distinguish between T1a and T1b tumors and to detect malignant lymph nodes are imprecise. This study aimed to review the accuracy of preoperative locoregional staging in superficial esophageal cancer in a Danish setting. This was a retrospective, multicenter study including patients with a cT1 esophageal tumor, both adenocarcinoma and squamous cell carcinoma. Patients receiving neoadjuvant treatment were excluded. Results from the preoperative diagnostics tools were compared with the pathology report to determine the diagnostic accuracy. Sixty-eight patients were included, 34 patients underwent esophagectomy, and 34 patients underwent endoscopic resection. The positive predictive value (PPV) of PET-CT (or CT) (when staged as a T1 tumor) was 77% (95%CI: 0.59–0.88), and the PPV of EUS (when staged as a T1a or T1b tumor) was 52% (95%CI: 0.32–0.72) and 60% (95%CI: 0.36–0.82), respectively. Six patients had malignant lymph nodes in the surgical specimen; none of them was identified before surgery. In conclusion, neither CT/PET-CT nor EUS is a precise tool to distinguish mucosal from submucosal esophageal tumors. Furthermore, in superficial malignant lesions, lymph node involvement is rare, but when present, it is rarely detected before surgery. To improve staging accuracy, all patients with cT1 tumors could be referred for a diagnostic endoscopic resection prior to possible other treatments.

  • Open Access

    Palliative Treatment of Esophageal Cancer Using Calcium Electroporation

    by Charlotte Egeland, Lene Baeksgaard, Julie Gehl, Ismail Gögenur, Michael Patrick Achiam

    Calcium electroporation (CaEP) is a novel cancer therapy wherein high intracellular calcium levels, facilitated by reversible electroporation, trigger tumor necrosis. This study aimed to establish safety with CaEP within esophageal cancer. Patients with non-curable esophageal cancer were included at Copenhagen University Hospital Rigshospitalet in 2021 and 2022. In an outpatient setting, calcium gluconate was injected intratumorally followed by reversible electroporation applied with an endoscopic electrode. The primary endpoint was the prevalence of adverse events, followed by palliation of dysphagia. All patients were evaluated with CT and upper endoscopies up to two months after treatment. The trial was registered at ClinicalTrials.gov (NCT04958044). Eight patients were treated. One serious adverse event (anemia, requiring a single blood transfusion) and three adverse events (mild retrosternal pain (two) and oral thrush (one)) were registered. Initially, six patients suffered from dysphagia: two reported dysphagia relief and four reported no change. From the imaging evaluation, one patient had a partial response, three patients had no response, and four patients had progression. Six months after treatment, the patient who responded well was still in good condition and without the need for further oncological treatment. CaEP was conducted in eight patients with only a few side effects. This study opens the way for larger studies evaluating tumor regression and symptom palliation.


  • Palliation of dysphagia in patients with non-curable esophageal cancer – a retrospective Danish study from a highly specialized center

    by Charlotte Egeland, Laser Arif Bazancir, Nam Hai Bui, Lene Baeksgaard, Julie Gehl, Ismail Gögenur, Michael Achiam

    Purpose A majority of the patients with esophageal cancer (EC) suffer from dysphagia. Several endoscopic treatment options are available such as stent placement, argon plasma coagulation, and esophageal dilatation. This study aimed to map the use of endoscopic dysphagia relieving interventions and secondly investigate possible impact on survival. Methods Data was collected at the Dept. of Surgery & Transplantation, Rigshospitalet, Denmark. Patients with non-curable EC referred from 2016 to 2019 were included. Type of dysphagia treatment, complications and the need for repeated treatments, and survival were registered. Results In the study, 601 patients were included. Forty-five percent were treated with an endoscopic procedure due to dysphagia (82% had a stent placed). The median time from diagnosis to intervention was 24 days. The overall complication rate was 35% (38% in the stent group and 20% in the non-stent group, p = 0.03) and 13% of the patients were readmitted due to a complication. After 26% of the procedures, a repeated treatment was required. Patients having an endoscopic intervention had a worsened survival prognosis compared with the patients in the non-intervention group (HR: 2.17, 95% CI: 1.80–2.61, p < 0.001). In the sub analysis where only patients who had an intervention was included, a survival difference in favor of the non-stent group was found (HR: 0.61, 95% CI: 0.43–0.86, p = 0.005). Conclusion In this cohort, the incidence of endoscopic procedures was high, complication rates were considerable, and many the patients required a second treatment. A survival difference was seen, where the patients who had a stent placed seemed to have the worst survival outcomes. However, the causal relationship is yet to be determined why the results must be interpreted carefully. New interventions and tailored approaches that may positively affect functional and long-term oncological outcomes are highly warranted and this should preferably be investigated in randomized clinical trials.


  • Severe Complications, Although Rare, Increase Length of Stay after Resection of Colorectal Liver Metastases

    by Charlotte K. Egeland, Andreas A. Rostved, Nikolai Aagaard Schultz, Hans-Christian Pommergaard, Thomas R. Daugaard, Line B. Thoefner, Jens Hillingsoe, Allan Rasmussen

  • Open Access

    Exercise-mediated improvement of depression in patients with gastro-esophageal junction cancer is linked to kynurenine metabolism

    by Anita Herrstedt, Marie L. Bay, Casper Simonsen, Anna Sundberg, Charlotte Egeland, Sarah Thorsen-Streit, Sissal S. Djurhuus, Per Magne Ueland, Øivind Midttun, Bente K. Pedersen, et al.

    Background: Exercise may improve depression in cancer patients, yet the molecular mechanism behind this protection is poorly understood. Here, we aimed to explore the link between exercise and regulation of kynurenine (Kyn) metabolism and inflammation in patients with operable gastro-esophageal junction (GEJ) cancer patients, who improved significantly in depression score with exercise training. Material and Methods: Fifty GEJ cancer patients were allocated to 12 weeks of supervised training twice weekly including interval-based aerobic exercise and resistance training, or standard care. Depression score was evaluated by HADS, and blood samples and muscle biopsies were collected for determination of Kyn metabolism and inflammation across the intervention. Results: Depression scores decreased by -1.3 points in the exercise group (p < 0.01), whereas no changes were observed in the control group. Plasma 3-hydroxykynurenine (HK), a Kyn metabolite giving rise to other neurotoxic metabolites, increased by 48% (p <0.001) in the control group, while exercise training attenuated this accumulation. The production of HK is induced by inflammation, and while we observed no differences in systemic pro-inflammatory cytokines, exercise training ameliorated the treatment-induced intramuscular inflammation. Moreover, exercise has been suggested to convert Kyn to the neuroprotective metabolite, kynurenic acid (KA), but despite marked functional and muscular exercise-mediated adaptations, we did not observe any enhancement of KA production and related enzyme expression in the muscles of GEJ cancer patients. Conclusion: Exercise training reduced symptoms of depression in patients with GEJ cancer, and this effect was associated with an exercise-dependent attenuation of the inflammation-induced conversion of Kyn to neurotoxic metabolites.


  • Open Access

    Endoscopic electrochemotherapy for esophageal cancer: a phase I clinical study

    by Charlotte Egeland, Lene Baeksgaard, Helle Hjorth Johannesen, Johan Löfgren, Christina Caroline Plaschke, Lars Bo Svendsen, Julie Gehl, Michael Patrick Achiam

    Background and study aims Esophageal cancer is on the rise in the western world and the disease has a poor 5-year survival prognosis below 20 %. Electrochemotherapy is a treatment where a chemotherapeutic drug is combined with locally applied electrical pulses, in order to increase the drug’s cytotoxicity in malignant cells. This study presents the first results with electrochemotherapy treatment in esophageal cancer. Patients and methods In this first-in-human trial, six patients with advanced esophageal cancer were treated with electrochemotherapy using intravenous bleomycin. All side effects and adverse events (AEs) were registered and the patients were later evaluated with gastroscopy and 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI). Results Treatment were well tolerated, main AEs being nausea, vomiting, oral thrush, pneumonia, retrosternal pain, fever, and hoarseness. No serious complications were observed. Five patients had a visual tumor response confirmed by gastroscopy. In two cases, these findings were confirmed with 18F-FDG PET/MRI as it revealed a reduction of total tumor mass. Conclusion Electrochemotherapy in patients with advanced esophageal cancer was conducted without major safety concerns. This study paves the way for larger studies, which may further elucidate response rates for and side effects of this new treatment.


  • Open Access

    Verrucous Squamous Cell Cancer in the Esophagus: An Obscure Diagnosis

    by Charlotte Egeland, Michael P. Achiam, Birgitte Federspiel, Lars Bo Svendsen

    Verrucous carcinoma is a rare, slow-growing type of squamous cell cancer. Fewer than 50 patients with verrucous carcinoma in the esophagus have been described worldwide. In 2014, two male patients were diagnosed with verrucous carcinoma in the distal part of the esophagus. The endoscopic examinations showed a similar wart-like, white, irregular mucosa in both cases. The diagnosis was difficult to make since all biopsies taken from the affected area showed no malignancy. This cancer type has a relatively good prognosis when the diagnosis is finally obtained. Both our patients presented with dysphagia, weight loss, and an endoscopically malignant tumor, but surgery was not performed until after 9 and 10 months, respectively, and then in order to get a diagnosis. At the last follow-up, both patients were without any recurrence of the disease.